Skip to main content

Medpace Holdings, Inc.

MEDP
Exchange
Nasdaq
Industry
Services-Commercial Physical & Biological Research
SEC CIK
0001668397

In the last 90 days, Medpace Holdings, Inc. insiders filed 0 open-market purchases and 18 sales; 699 institutions reported holding it in 13F filings for Q2 2026, worth $13.1B in total; superinvestors Giverny Capital and Fundsmith hold it.

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by Medpace Holdings, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
0 filings
Open-market sells
18 filings
7 insiders, $176.6M in total
Insiders trading
7
Net value
−$176.6M
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for Medpace Holdings, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for Medpace Holdings, Inc.
NameTitleLast reported holdingLast filingFilings, past year
Troendle August J.President & CEO389,456Sep 25, 202620
Burwig Susan EExec. VP, Operations65,984Sep 17, 202611
Kraft Robert O.Director955Aug 28, 20268
Brady Kevin M.CFO & Treasurer12,830Aug 24, 20263
Carley Brian TDirector27,825Aug 21, 20268
Davenport Fred B JrDirector3,798Aug 21, 20263
McCarthy Cornelius P. IIIDirector12,275Aug 13, 20268
Ewald Stephen PGeneral Counsel & Corp. Secy.20,343Jun 1, 20264
Gwadry-Sridhar Femida H.Director–May 18, 20261
Zander Dani S.Director–May 18, 20261
Geiger Jesse JPresident15,000Mar 19, 20263
Keating Ashley M.Director250May 21, 20240
Medpace Investors, LLC10% Owner4,733,019Mar 8, 20240
King Tom CDirector598May 24, 20220

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Jun 8, 2023 (view filing)Jun 6-72 daysMedpace Investors, LLC10% OwnerSSale−169.0K$222.15−$37.5M−2.6%6.28M after2 lots10b5-1
Jun 8, 2023 (view filing)Jun 6-72 daysTroendle August J.CEOSSale−169.0K$222.15−$37.5M−2.6%6.28M after2 lots10b5-1Duplicate filing
Jun 12, 2023 (view filing)Jun 84 daysMedpace Investors, LLC10% OwnerSSale−49.3K$220.85−$10.9M−0.8%6.23M after10b5-1
Jun 12, 2023 (view filing)Jun 84 daysTroendle August J.CEOSSale−49.3K$220.85−$10.9M−0.8%6.23M after10b5-1Duplicate filing
Jul 31, 2023 (view filing)Jul 274 daysEwald Stephen PGeneral Counsel & Corp. Secy.SSale−21.9K$254.39−$5.56M−59.5%14.9K after
Aug 2, 2023 (view filing)Jul 312 daysBrady Kevin M.CFO & TreasurerSSale−7.00K$255.00−$1.78M−53.8%6.00K after
Aug 16, 2023 (view filing)Aug 142 daysKraft Robert O.DirectorSSale−13.8K$265.67−$3.66M−98.7%188 after
Sep 20, 2023 (view filing)Sep 18-192 daysTroendle August J.CEOSSale−190.8K$263.89−$50.3M−3.1%6.04M after2 lots10b5-1
Sep 20, 2023 (view filing)Sep 18-192 daysMedpace Investors, LLC10% OwnerSSale−190.8K$263.89−$50.3M−3.1%6.04M after2 lots10b5-1Duplicate filing
Sep 21, 2023 (view filing)Sep 20-211 dayMedpace Investors, LLC10% OwnerSSale−127.3K$250.05−$31.8M−2.1%5.91M after2 lots10b5-1
Sep 21, 2023 (view filing)Sep 20-211 dayTroendle August J.CEOSSale−127.3K$250.05−$31.8M−2.1%5.91M after2 lots10b5-1Duplicate filing
Nov 16, 2023 (view filing)Nov 14-162 daysMedpace Investors, LLC10% OwnerSSale−75.0K$282.91−$21.2M−1.3%5.84M after3 lots
Nov 16, 2023 (view filing)Nov 14-162 daysTroendle August J.CEOSSale−75.0K$282.91−$21.2M−1.3%5.84M after3 lotsDuplicate filing
Nov 21, 2023 (view filing)Nov 17-204 daysTroendle August J.CEOSSale−100.0K$274.68−$27.5M−1.7%5.74M after2 lots
Nov 21, 2023 (view filing)Nov 17-204 daysMedpace Investors, LLC10% OwnerSSale−100.0K$274.68−$27.5M−1.7%5.74M after2 lotsDuplicate filing
Nov 22, 2023 (view filing)Nov 211 dayTroendle August J.CEOSSale−25.0K$277.37−$6.93M−0.4%5.71M after
Nov 22, 2023 (view filing)Nov 211 dayMedpace Investors, LLC10% OwnerSSale−25.0K$277.37−$6.93M−0.4%5.71M afterDuplicate filing
Nov 27, 2023 (view filing)Nov 225 daysMedpace Investors, LLC10% OwnerSSale−25.0K$277.81−$6.95M−0.4%5.69M after
Nov 27, 2023 (view filing)Nov 225 daysTroendle August J.CEOSSale−25.0K$277.81−$6.95M−0.4%5.69M afterDuplicate filing
Nov 29, 2023 (view filing)Nov 27-282 daysTroendle August J.CEOSSale−46.8K$274.96−$12.9M−0.8%5.64M after2 lots
Nov 29, 2023 (view filing)Nov 27-282 daysMedpace Investors, LLC10% OwnerSSale−46.8K$274.96−$12.9M−0.8%5.64M after2 lotsDuplicate filing
Dec 1, 2023 (view filing)Nov 29-Dec 12 daysMedpace Investors, LLC10% OwnerSSale−53.2K$272.86−$14.5M−0.9%5.59M after4 lots
Dec 1, 2023 (view filing)Nov 29-Dec 12 daysTroendle August J.CEOSSale−53.2K$272.86−$14.5M−0.9%5.59M after4 lotsDuplicate filing
Dec 18, 2023 (view filing)Dec 14-154 daysBurwig Susan EExec. VP, OperationsSSale−12.4K$303.96−$3.77M−44.8%15.3K after2 lots
Feb 21, 2024 (view filing)Feb 16-205 daysTroendle August J.CEOSSale−64.0K$390.58−$25.0M−1.1%5.53M after2 lots
Feb 21, 2024 (view filing)Feb 16-205 daysMedpace Investors, LLC10% OwnerSSale−64.0K$390.58−$25.0M−1.1%5.53M after2 lotsDuplicate filing
Feb 23, 2024 (view filing)Feb 21-222 daysTroendle August J.CEOSSale−136.0K$392.66−$53.4M−2.5%5.39M after2 lots
Feb 23, 2024 (view filing)Feb 21-222 daysMedpace Investors, LLC10% OwnerSSale−136.0K$392.66−$53.4M−2.5%5.39M after2 lotsDuplicate filing
Feb 27, 2024 (view filing)Feb 23-264 daysMedpace Investors, LLC10% OwnerSSale−156.9K$401.07−$62.9M−2.9%5.23M after2 lots
Feb 27, 2024 (view filing)Feb 23-264 daysTroendle August J.CEOSSale−156.9K$401.07−$62.9M−2.9%5.23M after2 lotsDuplicate filing
Feb 28, 2024 (view filing)Feb 262 daysKeating Ashley M.DirectorSSale−500$404.29−$202.1K−100.0%0 after2 lots
Feb 29, 2024 (view filing)Feb 27-282 daysMedpace Investors, LLC10% OwnerSSale−100.0K$403.01−$40.3M−1.9%5.13M after2 lots
Feb 29, 2024 (view filing)Feb 27-282 daysTroendle August J.CEOSSale−100.0K$403.01−$40.3M−1.9%5.13M after2 lotsDuplicate filing
Mar 1, 2024 (view filing)Feb 282 daysKeating Ashley M.DirectorSSale−500$405.00−$202.5K−100.0%0 after
Mar 1, 2024 (view filing)Feb 291 dayGeiger Jesse JPresidentSSale−2.56K$393.51−$1.01M−40.1%3.82K after
Mar 1, 2024 (view filing)Feb 29-Mar 11 dayEwald Stephen PGeneral Counsel & Corp. Secy.SSale−1.51K$395.19−$597.9K−10.2%13.3K after2 lots
Mar 4, 2024 (view filing)Feb 29-Mar 14 daysTroendle August J.CEOSSale−100.0K$400.25−$40.0M−1.9%5.03M after2 lots
Mar 4, 2024 (view filing)Feb 29-Mar 14 daysMedpace Investors, LLC10% OwnerSSale−100.0K$400.25−$40.0M−1.9%5.03M after2 lotsDuplicate filing
Mar 6, 2024 (view filing)Mar 4-52 daysMedpace Investors, LLC10% OwnerSSale−100.0K$402.91−$40.3M−2.0%4.93M after2 lots
Mar 6, 2024 (view filing)Mar 4-52 daysTroendle August J.CEOSSale−100.0K$402.91−$40.3M−2.0%4.93M after2 lotsDuplicate filing
Mar 6, 2024 (view filing)Mar 42 daysGeiger Jesse JPresidentSSale−22.3K$403.03−$9.00M−85.4%3.82K after
Mar 8, 2024 (view filing)Mar 71 dayKeating Ashley M.DirectorSSale−472$415.00−$195.9K−100.0%0 after
Mar 8, 2024 (view filing)Mar 6-82 daysMedpace Investors, LLC10% OwnerSSale−200.0K$411.61−$82.3M−4.1%4.73M after3 lots
Mar 8, 2024 (view filing)Mar 6-82 daysTroendle August J.CEOSSale−200.0K$411.61−$82.3M−4.1%4.73M after3 lotsDuplicate filing
Mar 18, 2024 (view filing)Mar 144 daysKeating Ashley M.DirectorSSale−250$409.87−$102.5K−50.0%250 after
Mar 19, 2024 (view filing)Mar 154 daysBurwig Susan EExec. VP, OperationsSSale−102$403.00−$41.1K−0.7%15.2K after
May 1, 2024 (view filing)Apr 29-302 daysTroendle August J.CEOSSale−16.9K$400.65−$6.78M−2.1%789.7K after2 lots
May 3, 2024 (view filing)May 1-22 daysTroendle August J.CEOSSale−16.3K$401.33−$6.55M−2.1%773.4K after2 lots
May 8, 2024 (view filing)May 6-72 daysTroendle August J.CEOSSale−52.4K$403.20−$21.1M−6.8%721.0K after2 lots
May 10, 2024 (view filing)May 8-92 daysTroendle August J.CEOSSale−8.27K$400.41−$3.31M−1.1%712.7K after2 lots